Search

Your search keyword '"Morrissey, Lisa"' showing total 135 results
Start Over Author "Morrissey, Lisa"
135 results on '"Morrissey, Lisa"'

1. CritCom: assessment of quality of interdisciplinary communication around deterioration in pediatric oncologic patients

Author

Rivera, Jocelyn, primary, Malone, Sara, additional, Puerto-Torres, Maria, additional, Prewitt, Kim, additional, Counts, Lara, additional, Wiphatphumiprates, Parima, additional, Sakaan, Firas, additional, Al Zebin, Zebin, additional, Arias, Anita V., additional, Bhattacharyya, Parthasarathi, additional, Gunasekera, Sanjeeva, additional, Johnson, Sherry, additional, Kambugu, Joyce, additional, Kaye, Erica C., additional, Mandrell, Belinda, additional, Mack, Jennifer, additional, McArthur, Jennifer, additional, Mendez, Alejandra, additional, Morrissey, Lisa, additional, Sharara-Chami, Rana, additional, Snaman, Jennifer, additional, Sniderman, Elizabeth, additional, Luke, Douglas A., additional, Graetz, Dylan E., additional, and Agulnik, Asya, additional

Published
2023
Full Text
View/download PDF

3. A new measure for multi-professional medical team communication: design and methodology for multilingual measurement development

Author

Malone, Sara, primary, Rivera, Jocelyn, additional, Puerto-Torres, Maria, additional, Prewitt, Kim, additional, Sakaan, Firas, additional, Counts, Lara, additional, Al Zebin, Zebin, additional, Arias, Anita V., additional, Bhattacharyya, Parthasarathi, additional, Gunasekera, Sanjeeva, additional, Johnson, Sherry, additional, Kambugu, Joyce, additional, Kaye, Erica C., additional, Mandrell, Belinda, additional, Mack, Jennifer W., additional, McArthur, Jennifer, additional, Mendez, Alejandra, additional, Morrissey, Lisa, additional, Sharara-Chami, Rana, additional, Snaman, Jennifer, additional, Sniderman, Elizabeth, additional, Luke, Douglas A., additional, Graetz, Dylan E., additional, and Agulnik, Asya, additional

Published
2023
Full Text
View/download PDF

7. Answers to common questions about COVID‐19 vaccines in children with cancer

Author

Caniza, Miguela A., primary, Homsi, Maysam R., additional, Bate, Jessica, additional, Adrizain, Riyadi, additional, Ahmed, Tarek, additional, Alexander, Sarah, additional, Bhattacharyya, Arpita, additional, Copado‐Gutierrez, Jose Luis, additional, Gutierrez, Ivan, additional, Lim, Yan Yin, additional, Morrissey, Lisa, additional, Naidu, Gita, additional, Paintsil, Vivian, additional, Radhakrishnan, Nita, additional, Mukkada, Sheena, additional, Phillips, Robert, additional, Alexander, Kenneth A., additional, and Pritchard‐Jones, Kathy, additional

Published
2022
Full Text
View/download PDF

8. SIOP Strategy 2021–2025: Cure for more, care for all

Author

Pritchard‐Jones, Kathy, primary, Challinor, Julia M., additional, Hunger, Stephen P., additional, Sung, Lillian, additional, Davidson, Alan, additional, Morrissey, Lisa K., additional, Khan, Muhammad Saghir, additional, Dalvi, Rashmi B., additional, Sullivan, Michael J., additional, Hessissen, Laila, additional, Chantada, Guillermo L., additional, Kearns, Pamela, additional, Frazier, A. Lindsay, additional, Wollaert, Susanne, additional, and Laub, Tzvetomira, additional

Published
2022
Full Text
View/download PDF

10. A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays

Author

Suarez, Amaranto, Piña, Martha, Nichols-Vinueza, Diana X., Lopera, John, Rengifo, Lyda, Mesa, Mauricio, Cardenas, Marcela, Morrissey, Lisa, Veintemilla, Galo, Vizcaino, Martha, Del Toro, Ligia, Vicuna, Victor, Fernandez, Jorge, Neuberg, Donna, Stevenson, Kristen, and Gutierrez, Alejandro

Published
2015
Full Text
View/download PDF

11. Yes I do want to be your little pony

Author

Morrissey, Lisa

Subjects
Bildkonst, Visual Arts
Abstract

Jag heter Lisa Morrissey och i min kandidatuppsats intervjuar jag Lisa Morrissey som arbetar med sin kandidatutställning på Konstfack. Uppsatsen baseras på Lisas tankar kring sin utställning och sitt konstnärskap samt mina egna vidarekopplingar från detta. Jag kommer att hålla mig till intervjun som grund och jag kommer även att förtydliga vissa begrepp och referenser som Lisa nämner. I slutet av uppsatsen reflekterar jag över några saker som tagits upp under samtalet.

Published
2021

13. Comment on: The COVID‐19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global

Author

Sullivan, Michael, Bouffet, Eric, Rodriguez‐Galindo, Carlos, Luna‐Fineman, Sandra, Khan, Muhammad Saghir, Kearns, Pam, Hawkins, Douglas S., Challinor, Julia, Morrissey, Lisa, Fuchs, Jörg, Marcus, Karen, Balduzzi, Adriana, Basset‐Salom, Luisa, Caniza, Miguela, Baker, Justin N., Kebudi, Rejin, Hessissen, Laila, Sullivan, Richard, Pritchard‐Jones, Kathy, Abdelhafeez, Abdelhafeez, Abib, Simone, Allan, Carl, Amayiri, Nisreen, Bailey, Simon, Biondi, Andrea, Baker, Justin, Bhakta, Nickhill, Boterberg, Tom, Bragança, João, Bustamante, Marisol, Calaminus, Gabriele, Cepelova, Michaela, Chantada, Guillermo L., Chintagumpala, Murali, Cole, Peter, Davidson, Alan, Dalvi, Rashmi, Doz, François, Esiashvili, Natia, Fernandez, Conrad, Figaji, Anthony, Frazier, Lindsay, Fouladi, Maryam, Hargrave, Darren, Hesseling, Peter B., Hoffman, Ruth Isabella, Howard, Scott C., Hunger, Stephen P., Graf, Norbert, Israels, Trijn, Karpelowsky, Jonathan, Kelly, Kara M., Koörholz, Dieter, Loh, Mignon, Mauz‐Körholz, Christine, Metzger, Monika, Molyneux, Elizabeth, Moreira, Daniel C., Moreno‐Ramirez, Arturo, Mukkada, Sheena, Mushtaq, Naureen, Parkes, Jeannette, Saab, Raya, Schmiegelow, Kjeld, Spreafico, Filippo, Heuvel‐Eibrink, Marry van den, Sullivan, M, Bouffet, E, Rodriguez-Galindo, C, Luna-Fineman, S, Khan, M, Kearns, P, Hawkins, D, Challinor, J, Morrissey, L, Fuchs, J, Marcus, K, Balduzzi, A, Basset-Salom, L, Caniza, M, Baker, J, Kebudi, R, Hessissen, L, Sullivan, R, and Pritchard-Jones, K

Subjects
Medical Oncology, Pediatrics, SARS‐CoV‐2, 0302 clinical medicine, Multidisciplinary approach, Risk Factors, Neoplasms, Health care, Pandemic, Medicine, Disease management (health), Child, Letter to the Editor, Societies, Medical, low-grade glioma, biology, Social distance, Burkitt lymphoma, Wilms tumor, Disease Management, Hematology, Oncology, 030220 oncology & carcinogenesis, nephroblastoma, Coronavirus Infections, medicine.medical_specialty, 2019-20 coronavirus outbreak, Consensus, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Pneumonia, Viral, Developing country, acute lymphoblastic leukemia, low‐grade glioma, retinoblastoma, 03 medical and health sciences, Betacoronavirus, Cog, COVID‐19, childhood cancer, Humans, Pediatrics, Perinatology, and Child Health, Letters to the Editor, Special Report, Pandemics, WHO Global Initiative on Childhood Cancer, business.industry, SARS-CoV-2, Cancer, COVID-19, biology.organism_classification, medicine.disease, Virology, pediatric, Family medicine, Pediatrics, Perinatology and Child Health, business, Hodgkin lymphoma, 030215 immunology
Abstract

The COVID‐19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment to children with cancer we have witnessed in the last few decades. This Special Report aims to summarize general principles for continuing multidisciplinary care during the SARS‐CoV‐2 (COVID‐19) pandemic. With contributions from the leadership of the International Society for Pediatric Oncology (SIOP), Children's Oncology Group (COG), St Jude Global program, and Childhood Cancer International, we have sought to provide a framework for healthcare teams caring for children with cancer during the pandemic. We anticipate the burden will fall particularly heavily on children, their families, and cancer services in low‐ and middle‐income countries. Therefore, we have brought together the relevant clinical leads from SIOP Europe, COG, and SIOP‐PODC (Pediatric Oncology in Developing Countries) to focus on the six most curable cancers that are part of the WHO Global Initiative in Childhood Cancer. We provide some practical advice for adapting diagnostic and treatment protocols for children with cancer during the pandemic, the measures taken to contain it (e.g., extreme social distancing), and how to prepare for the anticipated recovery period.

Published
2020

14. TITLE: The COVID-19 PANDEMIC: A Rapid Global response for Children with Cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI and St Jude Global

Author

Sullivan, Michael, Bouffet, Eric, Rodriguez-Galindo, Carlos, Luna-Fineman, Sandra, Khan, Muhammad Saghir, Kearns, Pam, Hawkins, Douglas S, Challinor, Julia, Morrissey, Lisa, Fuchs, Jörg, Marcus, Karen, Balduzzi, Adriana, Basset-Salom, Luisa, Caniza, Miguela, Baker, Justin N, Rejin Kebudi, Hessissen, Laila, Sullivan, Richard, and Pritchard-Jones, Kathy

Published
2020
Full Text
View/download PDF

16. The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global

Author

Sullivan, M, Bouffet, E, Rodriguez-Galindo, C, Luna-Fineman, S, Khan, M, Kearns, P, Hawkins, D, Challinor, J, Morrissey, L, Fuchs, J, Marcus, K, Balduzzi, A, Basset-Salom, L, Caniza, M, Baker, J, Kebudi, R, Hessissen, L, Sullivan, R, Pritchard-Jones, K, Sullivan, Michael, Bouffet, Eric, Rodriguez-Galindo, Carlos, Luna-Fineman, Sandra, Khan, Muhammad Saghir, Kearns, Pam, Hawkins, Douglas S, Challinor, Julia, Morrissey, Lisa, Fuchs, Jörg, Marcus, Karen, Balduzzi, Adriana, Basset-Salom, Luisa, Caniza, Miguela, Baker, Justin N, Kebudi, Rejin, Hessissen, Laila, Sullivan, Richard, Pritchard-Jones, Kathy, Sullivan, M, Bouffet, E, Rodriguez-Galindo, C, Luna-Fineman, S, Khan, M, Kearns, P, Hawkins, D, Challinor, J, Morrissey, L, Fuchs, J, Marcus, K, Balduzzi, A, Basset-Salom, L, Caniza, M, Baker, J, Kebudi, R, Hessissen, L, Sullivan, R, Pritchard-Jones, K, Sullivan, Michael, Bouffet, Eric, Rodriguez-Galindo, Carlos, Luna-Fineman, Sandra, Khan, Muhammad Saghir, Kearns, Pam, Hawkins, Douglas S, Challinor, Julia, Morrissey, Lisa, Fuchs, Jörg, Marcus, Karen, Balduzzi, Adriana, Basset-Salom, Luisa, Caniza, Miguela, Baker, Justin N, Kebudi, Rejin, Hessissen, Laila, Sullivan, Richard, and Pritchard-Jones, Kathy

Abstract

The COVID-19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment to children with cancer we have witnessed in the last few decades. This Special Report aims to summarize general principles for continuing multidisciplinary care during the SARS-CoV-2 (COVID-19) pandemic. With contributions from the leadership of the International Society for Pediatric Oncology (SIOP), Children's Oncology Group (COG), St Jude Global program, and Childhood Cancer International, we have sought to provide a framework for healthcare teams caring for children with cancer during the pandemic. We anticipate the burden will fall particularly heavily on children, their families, and cancer services in low- and middle-income countries. Therefore, we have brought together the relevant clinical leads from SIOP Europe, COG, and SIOP-PODC (Pediatric Oncology in Developing Countries) to focus on the six most curable cancers that are part of the WHO Global Initiative in Childhood Cancer. We provide some practical advice for adapting diagnostic and treatment protocols for children with cancer during the pandemic, the measures taken to contain it (e.g., extreme social distancing), and how to prepare for the anticipated recovery period.

Published
2020

17. The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA

Author

Pritchard-Jones, Kathy, primary, de C V Abib, Simone, additional, Esiashvili, Natia, additional, Kaspers, Gertjan J L, additional, Rosser, Jon, additional, Van Doorninck, John A, additional, Braganca, João M L, additional, Hoffman, Ruth I, additional, Rodriguez-Galindo, Carlos, additional, Adams, Cary, additional, Connor, Stephen R, additional, Abdelhafeez, Abdelhafeez H, additional, Bouffet, Eric, additional, Howard, Scott C, additional, Challinor, Julia M, additional, Hessissen, Laila, additional, Dalvi, Rashmi B, additional, Kearns, Pamela, additional, Chantada, Guillermo L, additional, Frazier, Lindsay A, additional, Sullivan, Michael J, additional, Schulte, Fiona SM, additional, Morrissey, Lisa K, additional, Kozhaeva, Olga, additional, Luna-Fineman, Sandra, additional, and Khan, Muhammad S, additional

Published
2021
Full Text
View/download PDF

29. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung carcinoma

Author

Hainsworth, John D., Morrissey, Lisa H., Scullin, Daniel C., Jr., Houston, Gerry Ann, Prasthofer, Edgar F., Gray, James R., Burris, Howard A., III, and Greco, F. Anthony

Subjects
Cancer -- Research, Medical research -- Analysis, Lung cancer, Small cell -- Drug therapy, Oral medication -- Dosage and administration, Paclitaxel -- Health aspects, Carboplatin -- Health aspects, Health
Published
2002

32. Development and Content Validation of an Instrument to Measure Baseline Standards for Pediatric Oncology Nursing in Low- and Middle-Income Countries.

Author

Day, Sara W., Sullivan, Courtney E., Morrissey, Lisa, Abramovitz, Linda, Segovia, Lorena, Punjwani, Rehana, and Challinor, Julia

Abstract

The Nursing Working Group of the International Society of Pediatric Oncology developed baseline standards for pediatric oncology nursing care in low- and middle-income countries. The standards represent the foundational support required to provide quality nursing care and address barriers such as inadequate staffing, lack of support, limited access to education, and unsafe nursing environments. The purpose of the current study was to develop and validate an instrument to accurately measure the standards. Content validity was assessed by a panel of expert pediatric oncology nurses from all geographical regions of the World Health Organization. The experts were informed about the study's purpose and provided the publications used to develop the instrument. The experts rated how well each criterion measured the corresponding standard by using a 4-point scale. A content validity index (CVI) was computed by using the percentage of total standards given a score of 3 or 4 by the experts. A CVI of.98 was obtained from the panel's evaluation. A CVI of more than.80 is recommended for a newly developed instrument. On the basis of the panel's recommendations, minor modifications were made to the instrument. We developed and validated the content of an instrument to accurately measure baseline standards for pediatric oncology nursing care. This instrument will aid future research on the effect of nursing standards on clinical outcomes, including mortality and abandonment of treatment, with the potential to influence health policy decisions and improve nursing support in low- and middle-income countries. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

38. The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global.

Author

Sullivan, Michael, Bouffet, Eric, Rodriguez‐Galindo, Carlos, Luna‐Fineman, Sandra, Khan, Muhammad Saghir, Kearns, Pam, Hawkins, Douglas S., Challinor, Julia, Morrissey, Lisa, Fuchs, Jörg, Marcus, Karen, Balduzzi, Adriana, Basset‐Salom, Luisa, Caniza, Miguela, Baker, Justin N., Kebudi, Rejin, Hessissen, Laila, Sullivan, Richard, Pritchard‐Jones, Kathy, and Rodriguez-Galindo, Carlos

Published
2020
Full Text
View/download PDF

41. A community-based program for personalized cancer care using next-generation sequencing (NGS).

Author

Liang, Shile, primary, Chandra, Pranil, additional, Ma, Zeqiang, additional, Haynes, Debbie, additional, Prescott, James, additional, Morrissey, Lisa H., additional, Jones, Suzanne Fields, additional, Spigel, David R., additional, Savona, Michael R., additional, Hainsworth, John D., additional, Infante, Jeffrey R., additional, and Burris, Howard A., additional

Published
2013
Full Text
View/download PDF

46. Paclitaxel/Carboplatin/Etoposide Versus Paclitaxel/Topotecan for Extensive‐Stage Small Cell Lung Cancer: A Minnie Pearl Cancer Research Network Randomized, Prospective Phase II Trial

Author

Greco, F. Anthony, primary, Thompson, Dana S., additional, Morrissey, Lisa H., additional, Erland, Joan B., additional, Burris, Howard A., additional, Spigel, David R., additional, Joseph, Geetha, additional, Corso, Steven W., additional, Spremulli, Ellen, additional, and Hainsworth, John D., additional

Published
2005
Full Text
View/download PDF

47. Carcinoma of Unknown Primary Site: Sequential Treatment with Paclitaxel/Carboplatin/Etoposide and Gemcitabine/Irinotecan: A Minnie Pearl Cancer Research Network Phase II Trial

Author

Greco, F. Anthony, primary, Rodriguez, Gladys I., additional, Shaffer, Don W., additional, Hermann, Robert, additional, Litchy, Sharlene, additional, Yardley, Denise A., additional, Burris, Howard A., additional, Morrissey, Lisa H., additional, Erland, Joan B., additional, and Hainsworth, John D., additional

Published
2004
Full Text
View/download PDF

49. Taxane-Based Chemotherapy for Patients with Carcinoma of Unknown Primary Site.

Author

Greco, F. Anthony, Gray, James, Burris, III, Howard A., Erland, Joan B., Morrissey, Lisa H., and Hainsworth, John D.

Subjects
ANTINEOPLASTIC agents, CANCER chemotherapy, DRUG efficacy
Abstract

Determines the efficacy of a taxane-based chemotherapy in patients with carcinoma of unknown primary site in Nashville, Tennessee. Schedule of the administration of the taxanes, paclitaxel and docetaxel; Tolerance of patients to the taxanes; Efficacy of the taxanes in the long-term survival of patients with cancer of unknown primary site.

Published
2001

50. Paclitaxel, Carboplatin, and Vinorelbine in the Treatment of Advanced Non-Small Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network.

Author

Hainsworth, John D., Burris III, Howard A., Morrissey, Lisa H., Thomas, Melodie, Erland, Joan B., Butts, James A., Joseph, Geetha, Kalman, Leonard, and Greco, F. Anthony

Subjects
PACLITAXEL, ANTINEOPLASTIC agents, VINORELBINE, SMALL cell lung cancer, COMBINATION drug therapy
Abstract

PURPOSE. To evaluate the feasibility, toxicity, and efficacy of adding vinorelbine to the paclitaxel/carboplatin combination in the treatment of advanced non-small cell lung cancer. PATIENTS AND METHODS. Patients with advanced (stage IIIB/IV) non-small cell lung cancer who had received no previous chemotherapy were treated with the following three-drug regimen: paclitaxel, 200 mg/m2, 1-hour IV infusion, day 1; carboplatin, AUC 6.0 IV, day 1; and vinorelbine, 22.5 rag/m2 IV days 1 and either 8 or 15. Treatment was repeated every 21 days. This phase II trial was conducted in a multicenter, community-based setting. RESULTS. Eighty-nine patients were treated with a median of four courses of therapy (range, one to eight). Thirty-one patients (35%) had major responses (two complete, 29 partial), and 36 patients (40%) had a minor response or stable disease. Actuarial median survival was 8.6 months; 1 year survival was 43%. Leukopenia was the major toxicity: 73% of patients had grade 3/4 toxicity, and 32 patients (36%) were hospitalized for neutropenia/fever (11% of total courses administered). Treatment-related death due to infection occurred in four patients (4%). CONCLUSIONS. This three-drug regimen is feasible and efficacious in the treatment of advanced non-small cell lung cancer. The addition of vinorelbine increases the incidence of severe leukopenia substantially when compared with the paclitaxel/carboplatin regimen. However, other toxicities are not markedly increased. Ongoing randomized trials will define the role of this regimen ill the treatment of non-small cell lung cancer. [ABSTRACT FROM AUTHOR]

Published
2000

Catalog

Books, media, physical & digital resources
See catalog results